Home › Menorrhagia › NCT05922657
A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device
A Prospective, Observational, Multi-center Study to Gather Real World Use Data on the Effectiveness, Safety, and Site-of-service of the Cerene Device
Who can join
Ages 25 and older · Women
Full eligibility criteria
Inclusion Criteria: * Scheduled for a Cerene treatment * 25 years of age and older * Provided informed consent to participate in the registry * English speaking * Agrees to complete a survey at specified time points from baseline to 12 Months Exclusion Criteria: * Physician discretion * Vulnerable populations
About the study
Channel Medsystems, Inc., the manufacturer of the Cerene® Cryotherapy Device (Cerene), is initiating a prospective, observational registry, the Progress registry, to gather data during real world utilization of the Cerene® Cryotherapy Device (Cerene). The primary objective of this registry is to bridge the gap between clinical results and outcomes achieved and reported during the pivotal study of Cerene and those obtained during its real-world use.
What is being tested
- Cerene (device)
Sponsor: Channel Medsystems · Participants: 300 · Started: Jun 9, 2023
Contact the study team
- Gerard Reilly, MD · Phone: 513-231-3447
- Brigette L. Tillman, RN · Phone: 513-231-3447
Official record on ClinicalTrials.gov — NCT05922657
Locations in the U.S.
| Ohio | Seven Hills Women's Health Centers, Cincinnati |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.